-
- Posts: 25
- Joined: Wed Apr 19, 2006 7:24 am
The API team at our site has developed a Normal phase method and the formulation -Analytical method is revese phase . The formulation cannot be analyzed on normal phase since it need to be diluted with water prior to analysis (since it is stock solution which needs to be reconstituted with water). Also in normal phase the detection wavelength is 315nm (the abs max for the compound is at 220nm and 315nm) since the mobile phase is mixture of chloroform and methanol. Incase of RP method the the detection is at 220nm.
Is it acceptable from regulatory point of view if the formulation is analyzed by reverse phase and the API method is normal phase?
I request you to kindly post your comments on the same.
Regards,
Yogesh
